FDA approvals are critical milestones for medical device companies, often leading to increased product sales and market penetration. Given the innovative nature of the Inceptiv device, this approval could significantly enhance Medtronic's reputation in pain management solutions, potentially increasing its stock value as investors react positively to the expansion of the company's product portfolio and its potential for generating additional revenue.